Wq. Zhu et al., The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins, BIOC BIOP R, 280(4), 2001, pp. 1183-1188
Citations number
49
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Galectin-3, a member of beta -galactoside-binding lectin family, is suggest
ed to be an AGE-receptor. To examine this possibility, we prepared CHO cell
s overexpressing human galectin-3 (galectin-3-CHO cells). Galectin-3-CHO ce
lls showed a specific and saturable binding to I-125-AGE-BSA with Kd of 3.1
mug/ml. I-125-AGE-BSA was endocytosed by galectin-3-CHO cells and underwen
t lysosomal degradation. The endocytosis of I-125-AGE-BSA was inhibited not
only by unlabeled AGE-BSA but also by acetylated LDL and oxidized LDL, lig
ands for the scavenger receptor family. Furthermore, I-125-oxidized LDL and
I-125-acetylated LDE were actively endocytosed by galectin-3-CHO cells and
the incubation with acetyl-LDL led to intracellular accumulation of choles
teryl esters, indicating the role of galectin-3 in endocytosis of AGE-prote
ins and modified LDLs. Since galectin-3 was localized and upregulated in fo
am cells at human atherosclerotic lesions, the present results suggest that
galectin-3 plays an important role in formation of atherosclerotic lesions
in vivo, by modulating endocytic uptake of AGE-proteins and modified LDLs.
(C) 2001 Academic Press.